NVS

#41
Novartis AG
153.66 USD
-0.45%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
153.63
153.84
Rango anual
104.93
170.46
Cambio diario
-0.45%
Variación mensual
-0.25%
Variación en los últimos 6 meses
+19.83%
Cambio anual
+40.14%
Cierres anteriores
154.35
Abrir
153.70
Bid
Ask
Mínimo
153.63
High
153.84
Volumen
163
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 293.21 B
  • Employee 75 K
  • Founded 1996
  • CEO Vasant Narasimhan
  • Website www.novartis.com
  • Headquarter Switzerland
  • FIGI BBG000LYF3S8
  • Industry Technology
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Novartis AG

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.

Noticias